Treatment Information

Back

Ovarian Cancer treatment details. Chemotherapy, Biologic therapy.

The West Clinic, Memphis, TN, United States.

Survival: monthsCountry:United States
Toxiciy Grade:4City/State/Province:Memphis, TN
Treatments:Chemotherapy, Biologic therapyHospital:The West Clinic
Drugs:Journal:Link
Date:Feb 2013

Description:

Patients:
This phase 2 study involved 48 primary epithelial ovarian or peritoneal carcinoma patients who had previously received platinum-based chemotherapy. The average patient age was 61.6 years.

Treatment:
Patients were treated with the biologic therapy agent bevacizumab and the chemotherapy agent ab-paclitaxel.

Toxicities:
The most severe toxicities were of grade 4 and included grade 3-4 intestinal perforation, vomiting, and infection.

Results:
The median overall survival was 17.15 months.

Support:
This study was supported by Genentech, Inc. and Abraxis BioScience/Celgene Corporation.

Correspondence: Dr. Todd D. Tillmanns; email: [email protected]



Back